Hawaiʻi's Department of Health has dropped new numbers that confirm what many insiders suspected: the state's medical cannabis program is already handling most of the patient load, and a regulated adult-use market could multiply overall cannabis spending several times over. The independent economic analysis pegs medical dispensary sales at about $5.3 million a month and estimates that total cannabis spending across all sources is already in the tens of millions. Those figures give lawmakers fresh ammunition for debates over taxes, tourism and public health costs.
Report overview and patient market
In a newsroom post, the Hawaiʻi Department of Health said the study, prepared for the DOH Office of Medical Cannabis Control and Regulation, finds that the regulated medical market captures roughly 86 to 87 percent of patient spending and that licensed medical dispensaries record about $5.3 million in monthly sales. The department pointed to the report as evidence that Hawaiʻi's medical program "is effectively serving patient needs" while warning that any move into adult-use will arrive with public health costs attached. Read the department's announcement at the Hawaiʻi Department of Health.
How big could an adult-use market be?
The report by Cannabis Public Policy Consulting estimates that total monthly cannabis demand across all sources currently runs somewhere between about $16.5 million and $32 million. It projects that a mature adult-use market could climb to $59 million to $95 million per month by year five, or about $46 million to $90 million per month after a modeled 15 percent tax. The analysis also concludes that tourists would add at least $11.5 million per month to overall demand and that Hawaiʻi would likely need around 65 retail outlets statewide in the first year to keep pace with projected consumption. Read the full analysis in the Cannabis Public Policy Consulting report.
Public health tradeoffs
OMCCR Program Manager Andrew Goff told the department that the findings underscore the need to balance any new revenue against public health protections and to steer those dollars toward prevention, treatment and workforce development. Both the press release and the report stress investment in prevention, education and treatment in order to reduce harms such as cannabis use disorder, youth exposure and drug-impaired driving. Read the department statement at the Hawaiʻi Department of Health.
Where this leaves lawmakers
Legislators already gaming out legalization proposals now have data-driven estimates on demand and revenue to bring into the room. One example is House Bill 1246, which would establish a Hawaiʻi Cannabis and Hemp Office and lay out tax and licensing frameworks for adult-use sales. Local coverage of the bill notes that industry advocates and public health officials alike are weighing potential tax windfalls against possible social costs. See local reporting on the bill in Maui Now.
What regulators will watch next
The analysis sketches out what a scaled-up system could look like, modeling cultivation and retail needs that range from tens of thousands of harvested plants each year to dozens of indoor or outdoor grow sites. It recommends flexible licensing, scaled fees and equity measures designed to give legacy growers and small businesses a foothold. Regulators will also have to settle on tax rates, testing standards and how to channel any new revenue into mitigating harms while keeping medical access intact for patients. For the full methodology and modeling tables, see the Cannabis Public Policy Consulting report.
